Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

3 Dividend Stocks to Double Up on Right Now
3 Dividend Stocks to Double Up on Right Now

If you are a long-term income investor looking for dividend stocks to add to your portfolio, now is a good time to consider Enterprise Products Partners (NYSE: EPD), Bank of Nova Scotia (NYSE: BNS)

Why Oklo Stock Slumped 6.3% Today
Why Oklo Stock Slumped 6.3% Today

Shares of Oklo (NYSE: OKLO) fell today, finishing down 6.3%. The decline came as the S&P 500 and Nasdaq Composite rose 0.1% and 0.3%, respectively.

Oklo, a nuclear energy company developing small

3 Top Dividend Stocks to Buy in December
3 Top Dividend Stocks to Buy in December

If you are underwhelmed with the S&P 500's (SNPINDEX: ^GSPC) skinny little 1.2% yield, don't fret. There are other, higher-yielding options at your disposal. Some of the choices, like Enterprise

Prediction: This Artificial Intelligence (AI) Stock Will Be Worth More Than Palantir in 2026
Prediction: This Artificial Intelligence (AI) Stock Will Be Worth More Than Palantir in 2026

When OpenAI released ChatGPT to the masses at the end of November 2022, Palantir Technologies (NASDAQ: PLTR) had a $12.5 billion market capitalization. Today, the data-mining darling is worth more

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?
Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now?

Did you know that Summit Therapeutics (NASDAQ: SMMT) is one of the few publicly traded companies that has a market cap of more than $10 billion, but no revenue? With that kind of a valuation and

Oklo Stock Is Up More Than 400% This Year. Here's Why I Wouldn't Buy It -- Yet
Oklo Stock Is Up More Than 400% This Year. Here's Why I Wouldn't Buy It -- Yet

Sometimes, as an investor, you find a company you love. It's an innovator, or it's working on some very cool technology, or it's got some new way of doing business that's making waves in its

Is Oklo Stock Your Ticket to Nuclear Energy Riches?
Is Oklo Stock Your Ticket to Nuclear Energy Riches?

Oklo (NYSE: OKLO) has been on a hot streak. After a disastrous debut, in which the nuclear power stock plunged over 50% on its first trading day, Oklo's share price has rebounded sharply. Indeed, by

What AMD, CoreWeave, and Nebius Stock Investors Should Know About Recent Investor Conferences
What AMD, CoreWeave, and Nebius Stock Investors Should Know About Recent Investor Conferences

In today's video, I discuss recent updates affecting Advanced Micro Devices (NASDAQ: AMD), CoreWeave (NASDAQ: CRWV), and other AI stocks. To learn more, check out the short video, consider

Why Did Serve Robotics Stock Rocket Over 25% Higher This Week?
Why Did Serve Robotics Stock Rocket Over 25% Higher This Week?

Serve Robotics (NASDAQ: SERV) stock has been up and down this year. After hitting a 2025 high of about $23 per share, it tanked as low as almost $5. Serve shares now trade at around $13 per share

Why Innodata Stock Lost 23% in November
Why Innodata Stock Lost 23% in November

Shares of Innodata (NASDAQ: INOD), an AI stock focused on data-labeling, were pulling back last month as the stock reacted to concerns about the AI bubble bursting and an underwhelming earnings

Why a $10 Million Bet on Core Scientific Stock Could Pay Off After Its Recent Reset
Why a $10 Million Bet on Core Scientific Stock Could Pay Off After Its Recent Reset

New York City-based Kintayl Capital disclosed a new stake in Core Scientific (NASDAQ:CORZ) valued at approximately $10.2 million, according to its November 14 SEC filing.

Kintayl Capital LP

Why Investors Were Buzzing About Curaleaf Stock Today
Why Investors Were Buzzing About Curaleaf Stock Today

Marijuana company Curaleaf (OTC: CURLF) is expanding its presence in a potentially massive market, a move that resonated with investors on Thursday. That, plus a new weed reform resolution filed in

Value Fund Dumps $10.1 Million Eastman Chemical Stake as Stock Slump Continues and EBIT Drops 43%
Value Fund Dumps $10.1 Million Eastman Chemical Stake as Stock Slump Continues and EBIT Drops 43%

New York City-based Atlantic Investment Management fully exited its position in Eastman Chemical Company (NYSE:EMN) in the third quarter, reducing holdings by 134,710 shares and approximately $10.1

Graphic Packaging Stock Is Slumping — But a New $12.6 Million Stake Signals a Value Play
Graphic Packaging Stock Is Slumping — But a New $12.6 Million Stake Signals a Value Play

New York City-based Atlantic Investment Management initiated a new position in Graphic Packaging Holding Company (GPK), adding 645,584 shares valued at approximately $12.6 million, according to a

Why One Fund Put 12.6% of Its Portfolio Into Axalta — and What $294M EBITDA Says About the Stock
Why One Fund Put 12.6% of Its Portfolio Into Axalta — and What $294M EBITDA Says About the Stock

New York City-based Atlantic Investment Management disclosed a new position in Axalta Coating Systems (NYSE:AXTA) in its November 14 SEC filing, acquiring 764,000 shares valued at approximately

3 Growth Beasts That Have Beaten the Market in 8 of the Past 10 Years
3 Growth Beasts That Have Beaten the Market in 8 of the Past 10 Years

For a stock to routinely beat the market is no easy task. The S&P 500 is a collection of the leading 500 stocks in the U.S. markets, and mirroring the index has been a great way for investors to

This Nearly 6.7%-Yielding Dividend Just Keeps Heading Higher
This Nearly 6.7%-Yielding Dividend Just Keeps Heading Higher

The first thing you need to know about Enterprise Products Partners (NYSE: EPD) if you are a dividend investor is that its yield is juicy 6.7%. The second thing is that this midstream master limited

Why Richtech Robotics Stock Was a Major Winner on Wednesday
Why Richtech Robotics Stock Was a Major Winner on Wednesday

The U.S. federal government appears to be throwing its considerable weight behind the development of robots in the country. News of this gave some real power to stocks in the industry on Wednesday

Ignore AMC Stock in 2026 and Load Up on This Movie Theater Stock Instead
Ignore AMC Stock in 2026 and Load Up on This Movie Theater Stock Instead

Shares of iconic movie theater operator AMC (NYSE: AMC) have continued to disappoint: As of Dec. 1, they were down by more than 41% this year. Unfortunately, AMC finds itself in a business that has

Why Oklo Stock Popped -- Then Gave It All Back Today
Why Oklo Stock Popped -- Then Gave It All Back Today

Start-up atomic technology stock Oklo (NYSE: OKLO), one of the breakout stars of 2025, jumped 5% in early trading Wednesday morning after UBS analyst Jon Windham raised his price target on the

Is Core Scientific’s AI Pivot Working? New Investor Takes Big $22 Million Position
Is Core Scientific’s AI Pivot Working? New Investor Takes Big $22 Million Position

On November 14, asset manager VR Advisory Services disclosed a new position in Core Scientific (NASDAQ:CORZ), acquiring 1.2 million shares—an estimated $21.7 million stake.

According to a filing

Why Is Airbus Stock Up Today?
Why Is Airbus Stock Up Today?

After three days of steadily falling stock prices, shares of European plane-maker Airbus SE (OTC: EADSY) finally turned around this morning and headed higher. As of 10:40 a.m. ET, the aerospace

AMC's New Trick Is Crazy Enough to Work
AMC's New Trick Is Crazy Enough to Work

There are a lot of bad ideas on the slippery path of a downward spiral. AMC Entertainment (NYSE: AMC) has gone through its share of misfires, as the stock has plunged 99.7% since notching an

Is This Growth Stock Still a Buy After a 20% Pullback?
Is This Growth Stock Still a Buy After a 20% Pullback?

In this video, I will talk about the recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and why I remain bullish on the name. Watch the short video to learn more, consider subscribing

Don't Buy Summit Therapeutics Until This Big Thing Happen
Don't Buy Summit Therapeutics Until This Big Thing Happen

Sometimes, everything can seem to be going your way. And then the wheels fall off. That's the situation Summit Therapeutics (NASDAQ: SMMT) finds itself in.

Shares of the clinical-stage biotech